If you have been reading about Chelation and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Practical handling notes centre on limiting exposure to water, oxygen, and repeated temperature cycling. Weighed powder is often equilibrated to room temperature before opening to avoid condensation on the solid. Working solutions are typically divided into single-use aliquots and frozen rather than stored refrigerated for long periods. Reported shelf lives vary widely between laboratories, and no single set of conditions is universally treated as a reference standard, which complicates direct comparison of published stability figures.
Solutions of GHK-Cu respond strongly to pH, redox conditions, and the presence of competing chelators such as EDTA. Below roughly pH 4 the copper tends to dissociate, because the amide nitrogen donors become protonated and can no longer coordinate. Strongly alkaline conditions instead favour hydrolysis and precipitation of copper hydroxide. Dissolved oxygen and light accelerate breakdown of the peptide backbone, and the copper released during that process can catalyse further oxidation, so dry, cold, dark storage is the usual recommendation.
Routine characterisation relies on reversed-phase high-performance liquid chromatography for peptide purity, paired with mass spectrometry for identity confirmation. Ultraviolet-visible spectroscopy detects the metal centre through its absorption band in the visible region, and inductively coupled plasma mass spectrometry quantifies total copper so that a metal-to-peptide ratio can be calculated. Amino acid analysis confirms the expected residue composition. Together these techniques establish concentration, identity, and stoichiometry, but none of them directly reports biological activity.
The sequence carries three residues in the order glycine, histidine, lysine, which places a small, flexible chain around a single metal centre. Compared with larger copper-binding proteins, the complex is compact and its coordination chemistry can be reproduced with synthetic peptide in a laboratory. Published structural work agrees on the nitrogen donor set but differs in the exact geometry assigned under some conditions, so the arrangement is best treated as well characterised in outline rather than fixed in every detail.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide was isolated from human plasma in the early 1970s by Loren Pickart, who observed that a plasma fraction from young donors stimulated growth in cultured liver cells. The copper-bound form is abbreviated GHK-Cu, while the metal-free peptide is written simply as GHK. In the research literature the complex also appears as copper tripeptide-1 and as glycyl-histidyl-lysine copper complex.
Copper(II) binds the peptide through four nitrogen donors: the terminal amino group, the imidazole nitrogen of histidine, and two deprotonated amide nitrogens of the peptide backbone. This tetradentate arrangement gives a roughly square-planar geometry, the thermodynamically favoured form near neutral pH. Because the amide nitrogens must lose a proton before they can coordinate, complex formation is strongly pH-dependent, and the fully coordinated species dominates only above mildly acidic conditions. Electronic transitions within the copper d orbital set produce the characteristic blue to violet colour in aqueous solution.
| Property | Value | Notes |
|---|---|---|
| Typical peptide purity | 95% or higher by HPLC | Research-grade material; varies by supplier |
| Copper-to-peptide ratio | Approximately 1 to 1 | Determined by elemental analysis plus peptide assay |
| Visible absorption | Roughly 525 to 600 nm | Position shifts with pH and coordination state |
| Common counter-ions | Acetate, trifluoroacetate | Affect mass, solubility, and handling behaviour |
| Preferred storage form | Lyophilised powder, desiccated | Cold and dark; solutions are markedly less stable |
Handling practices for the solid material emphasise low temperature and dryness. The lyophilised or powdered form is typically kept at refrigerator or freezer temperatures together with a desiccant. Working solutions are often prepared fresh, because repeated freeze-thaw cycles and extended storage may alter the complex. Glass or inert plastic containers are preferred over materials that could leach metal ions into the preparation. Such practices follow general peptide conventions rather than substance-specific regulations.
Analytical verification commonly relies on high-performance liquid chromatography for purity assessment and mass spectrometry for identity confirmation. Spectroscopic methods such as UV-visible absorption and electron paramagnetic resonance can probe the metal centre itself, since the d9 configuration of copper(II) produces characteristic signals. Elemental analysis or plasma-based techniques quantify copper content. Because each method reports a different aspect of the same sample, purity figures are most meaningful when the technique and its detection wavelength are stated alongside the value.
Stability of the complex in solution depends on pH, temperature, and the presence of competing ligands. It is generally described as more resistant to breakdown than the metal-free chain, since coordination reduces susceptibility to enzymatic attack. Oxidation and hydrolysis can nevertheless proceed over time in aqueous media. Storage guidance in laboratory settings commonly involves refrigeration, protection from light, and avoidance of strongly alkaline conditions. Published data on long-term behaviour vary considerably and depend on the specific matrix.
GHK-Cu is a coordination complex formed between the peptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The unbound chain, abbreviated GHK, consists of three amino acids and occurs naturally in human plasma, saliva, and urine. Binding of the metal is mediated mainly by the imidazole nitrogen of the histidine residue together with backbone amides, producing a stable chelate. Ingredient nomenclature often lists the same substance as copper tripeptide-1. Its charge and solubility behaviour differ from those of the metal-free chain.
The copper-binding activity of this sequence was described in the 1970s during studies of liver tissue and plasma factors. Early work identified the peptide as a component that influenced copper uptake by cells and that appeared in wound fluid. Later investigations examined its presence across species, reporting the same chain in human and animal samples. A decline in measured concentration with age became a recurring observation, although the underlying causes remain incompletely characterised.
Published studies describe the complex in several research contexts, including collagen synthesis, antioxidant behaviour, and wound repair models. Much of this work is conducted in cultured cells or in small animal systems, and the findings are frequently cited in reviews of copper peptides. Direct clinical evidence in humans is comparatively limited, and reported outcomes vary with formulation and study design. Whether free chain or metal-bound form was used is not always stated, a point that complicates comparison between reports.
Dry material is normally held cold, commonly at -20 °C for long-term storage and 2 to 8 °C for working quantities, protected from light and moisture. Vials should be allowed to reach room temperature before opening so that condensation does not form on the powder. In liquid formulations the complex is generally kept near neutral to slightly acidic pH, because strongly alkaline conditions favour precipitation of copper hydroxide. Antioxidants or chelate-stabilising excipients are often added, though the specific approaches are proprietary and rarely published in detail.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry to confirm the expected mass. Copper content is measured separately by inductively coupled plasma optical emission spectrometry or atomic absorption spectroscopy, because the peptide assay alone does not establish the metal-to-peptide ratio. Visible spectroscopy provides a rapid check on complex integrity through the absorption band in the visible region. Agreement between the peptide assay and the copper assay is the practical test of whether a sample is the intended complex rather than a mixture.
Aqueous solutions of GHK-Cu are less stable than the dry powder. The peptide backbone is vulnerable to hydrolysis at extreme pH, and copper can be stripped from the complex by strong chelating agents such as EDTA or citrate. Oxidising agents and high concentrations of ascorbic acid can reduce copper(II) and change the complex, which is one reason formulators often keep such ingredients in separate phases. How quickly these changes occur under real storage conditions depends on pH, buffer, temperature and packaging, and quantitative data on the subject are limited.
== Spermidin und Krebs == Bei der Entstehung von Krebs und dem Fortschreiten des beinahe grenzenlosen Wachstums der Krebszellen spielen Spermidin und Spermin eine wichtige Rolle. Schnell wachsende Tumorzellen besitzen einen erhöhten Gehalt an Putrescin und Spermidin aufgrund einer durch Onkogene wie MYC deregulierten Polyamin-Homöostase. Eine erhöhte Polyaminaufnahme in Immunzellen verringert die anti-Tumor Immunität. Deshalb sind die Hemmung der Polyamin-Biosynthese mit DFMO sowie der -Interkonversion, ihr verstärkter Abbau, Verhinderung der Aufnahme mit der Nahrung und aus dem Darm-Mikrobiom, die Hemmung des Transports in die Zelle sowie Einschränkungen ihrer Funktion gut begründete Ziele für medikamentöse Therapieansätze (polyamine blocking therapy, PBT). Die für die Biosynthese von Spermidin und Spermin verantwortlichen Enzyme ODC und S-Adenosylmethionin-Decarboxylase (SAM-DC) sowie Spermidin- und Spermin-Synthase sind in Krebszellen besonders aktiv. Dabei ist zur Verhinderung des Krebswachstums und der Metastasierung die gezielte Kombination von Chemotherapeutika mit Substanzen zur Verringerung des zellulären Gehalts an Putrescin und Spermidin einer Monotherapie überlegen, denn sie erlaubt kleinere individuelle Dosen und damit eine verringerte Toxizität.
Spermidin ist notwendig für die Biosynthese des für die Initiierung der Proteinsynthese zuständigen Translationsfaktors eIF-5A. Dabei wird der Aminobutyl-Teil von Spermidin auf einen Lysylrest von pro-eIF-5A übertragen, wobei zunächst die ungewöhnliche Aminosäure Deoxy-Hypusin und in der Folge Hypusin entsteht. Diese posttranslationale Bildung von Hypusin ist eine notwendige Voraussetzung für die Zellproliferation, auch von Krebszellen.
== Effekt auf das Altern == In Tierexperimenten (Fruchtfliegen und Mausmodellen) zeigte Spermidin neuroprotektive und kardioprotektive Effekte sowie eine Verlängerung der Lebensspanne. Die beobachteten Effekte umfassten unter anderem eine Verbesserung der Herzfunktion, eine Senkung des Blutdrucks und protektive Wirkungen auf Herz- und Nierenfunktion. Ob vergleichbare Effekte beim Menschen auftreten, ist bislang nicht gesichert. An einer klinischen Untersuchung über einen zwanzigjährigen Beobachtungszeitraum (1995–2015) nahmen 829 zwischen 45 und 84 Jahre alte Menschen (Männeranteil bei 50 Prozent) teil. Dabei wurde die Aufnahme von Spermidin in den Ernährungsgewohnheiten dieser Personengruppe mit Fragebögen protokolliert. In diesem Zeitraum starben 341 der Personen. Nach einer Korrektur für Alter, Geschlecht und Kalorienzufuhr betrug das statistische Mortalitätsrisiko 48 Prozent bei den Probanden im unteren Drittel der Spermidinaufnahme, 41 Prozent im mittleren und 38 Prozent im oberen Drittel. Für die Probanden mit der höchsten protokollierten Nahrungsaufnahme von Spermidin wurde ein um 5,7 Jahre verlängertes Leben im Vergleich zur Gruppe mit der geringsten Aufnahme berechnet. Die Resultate dieser Ernährungsstudie unterliegen aber begründetem Zweifel hinsichtlich der tatsächlichen Aufnahme von Inhaltsstoffen mit der berichteten Nahrung.
Sources: de.wikipedia.org
Die vorhandenen wissenschaftlichen Belege reichen nicht aus, um spermidinhaltigen Nahrungsergänzungsmitteln beim Menschen einen Nutzen zur Prävention von Alterserscheinungen zuzuschreiben, auch hinsichtlich ihres noch unerforschten, tumorfördernden Potentials. Die Verbraucherzentrale sieht einen Mangel von Nachweisen für den gewünschten Longevity-Effekt und warnt vor zu hohen Erwartungen bei einseitiger Ernährung. Gesundheitsbezogene Werbeaussagen für Spermidin sind nicht zugelassen.
Sources: de.wikipedia.org
Inductively coupled plasma mass spectrometry or atomic absorption spectroscopy gives total copper after acid digestion. Combining that value with a peptide concentration from chromatography or amino acid analysis yields the metal-to-peptide ratio.
The colour arises from electronic transitions within the copper(II) d orbital set, which absorb visible light. The absorption maximum shifts with pH and with the number of nitrogen donors bound, so the spectrum serves as a rough probe of coordination state.
Aqueous solutions degrade faster than dry powder, because hydrolysis, oxidation, and metal dissociation all proceed in water. Dividing solutions into small aliquots and freezing them limits repeated freeze-thaw cycles. Exact shelf lives are not well established and depend on concentration and buffer.
It consists of a three-amino-acid peptide, glycine-histidine-lysine, bound to one copper(II) ion. The peptide supplies four nitrogen donor atoms, and the resulting complex is stable in neutral aqueous solution. The metal-free peptide is usually called GHK.